337 related articles for article (PubMed ID: 21785996)
1. Pathogenesis of the tauopathies.
Goedert M; Spillantini MG
J Mol Neurosci; 2011 Nov; 45(3):425-31. PubMed ID: 21785996
[TBL] [Abstract][Full Text] [Related]
2. Tau and tauopathies.
Lee G; Leugers CJ
Prog Mol Biol Transl Sci; 2012; 107():263-93. PubMed ID: 22482453
[TBL] [Abstract][Full Text] [Related]
3. Anatamopathological spectrum of tauopathies.
Revesz T; Holton JL
Mov Disord; 2003 Sep; 18 Suppl 6():S13-20. PubMed ID: 14502651
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the tau gene (MAPT) in FTDP-17: the family with Multiple System Tauopathy with Presenile Dementia (MSTD).
Spillantini MG; Murrell JR; Goedert M; Farlow M; Klug A; Ghetti B
J Alzheimers Dis; 2006; 9(3 Suppl):373-80. PubMed ID: 16914875
[TBL] [Abstract][Full Text] [Related]
5. Hereditary frontotemporal dementia caused by Tau gene mutations.
van Swieten J; Spillantini MG
Brain Pathol; 2007 Jan; 17(1):63-73. PubMed ID: 17493040
[TBL] [Abstract][Full Text] [Related]
6. MAPT mutations, tauopathy, and mechanisms of neurodegeneration.
Strang KH; Golde TE; Giasson BI
Lab Invest; 2019 Jul; 99(7):912-928. PubMed ID: 30742061
[TBL] [Abstract][Full Text] [Related]
7. Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies.
de Silva R; Lashley T; Gibb G; Hanger D; Hope A; Reid A; Bandopadhyay R; Utton M; Strand C; Jowett T; Khan N; Anderton B; Wood N; Holton J; Revesz T; Lees A
Neuropathol Appl Neurobiol; 2003 Jun; 29(3):288-302. PubMed ID: 12787326
[TBL] [Abstract][Full Text] [Related]
8. Tau protein and neurodegeneration.
Goedert M
Semin Cell Dev Biol; 2004 Feb; 15(1):45-9. PubMed ID: 15036206
[TBL] [Abstract][Full Text] [Related]
9. Untangling the tauopathies: Current concepts of tau pathology and neurodegeneration.
Ling H
Parkinsonism Relat Disord; 2018 Jan; 46 Suppl 1():S34-S38. PubMed ID: 28789904
[TBL] [Abstract][Full Text] [Related]
10. Different tau species lead to heterogeneous tau pathology propagation and misfolding.
Dujardin S; Bégard S; Caillierez R; Lachaud C; Carrier S; Lieger S; Gonzalez JA; Deramecourt V; Déglon N; Maurage CA; Frosch MP; Hyman BT; Colin M; Buée L
Acta Neuropathol Commun; 2018 Nov; 6(1):132. PubMed ID: 30497516
[TBL] [Abstract][Full Text] [Related]
11. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
Stancu IC; Ferraiolo M; Terwel D; Dewachter I
Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
[TBL] [Abstract][Full Text] [Related]
12. The role of tau phosphorylation and cleavage in neuronal cell death.
Chun W; Johnson GV
Front Biosci; 2007 Jan; 12():733-56. PubMed ID: 17127334
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings.
Lees AJ
Mov Disord; 2003 Sep; 18 Suppl 6():S28-33. PubMed ID: 14502653
[TBL] [Abstract][Full Text] [Related]
14. Cellular and pathological heterogeneity of primary tauopathies.
Chung DC; Roemer S; Petrucelli L; Dickson DW
Mol Neurodegener; 2021 Aug; 16(1):57. PubMed ID: 34425874
[TBL] [Abstract][Full Text] [Related]
15. [The genetics of dementias. Part 1: Molecular basis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)].
Kowalska A
Postepy Hig Med Dosw (Online); 2009 Jun; 63():278-86. PubMed ID: 19535823
[TBL] [Abstract][Full Text] [Related]
16. Tau and neurodegeneration.
Goedert M; Crowther RA; Scheres SHW; Spillantini MG
Cytoskeleton (Hoboken); 2024 Jan; 81(1):95-102. PubMed ID: 38073060
[TBL] [Abstract][Full Text] [Related]
17. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy.
Zhang B; Higuchi M; Yoshiyama Y; Ishihara T; Forman MS; Martinez D; Joyce S; Trojanowski JQ; Lee VM
J Neurosci; 2004 May; 24(19):4657-67. PubMed ID: 15140937
[TBL] [Abstract][Full Text] [Related]
18. Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration.
Higuchi M; Ishihara T; Zhang B; Hong M; Andreadis A; Trojanowski J; Lee VM
Neuron; 2002 Aug; 35(3):433-46. PubMed ID: 12165467
[TBL] [Abstract][Full Text] [Related]
19. Tau Isoforms: Gaining Insight into
Corsi A; Bombieri C; Valenti MT; Romanelli MG
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499709
[TBL] [Abstract][Full Text] [Related]
20. Tau isoform composition influences rate and extent of filament formation.
Zhong Q; Congdon EE; Nagaraja HN; Kuret J
J Biol Chem; 2012 Jun; 287(24):20711-9. PubMed ID: 22539343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
